Fact CheckerSign in

NCT06421545Completed

Resilient Together for Dementia

Resilient Together for Dementia: A Live Video Resiliency Dyadic Intervention for Persons With Dementia and Their Care-partners Early After Diagnosis

Source: ClinicalTrials.gov · Last updated 30 Mar 2025

Brief summary (registry, in English)

The proposed study will establish the feasibility, acceptability and credibility of a novel live video dyadic resiliency intervention, Resilient Together for Dementia (RT-D), aimed at preventing chronic emotional distress and preserving quality of life among dyads at risk for chronic emotional distress early after a diagnosis of Alzheimer's disease or a related dementia (ADRD).

Status (registry)
Completed
Study type
Interventional
Enrollment
12 (actual)
First submitted
30 Apr 2024
Start date
19 Apr 2024
Primary completion date
6 Mar 2025
Lead sponsor
Icahn School of Medicine at Mount Sinai
NCT number
NCT06421545

What you commit to

  • Study type: Interventional
  • Participants enrolled: 12
  • From 19 Apr 2024 to the primary completion date, 6 Mar 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • either partner has a co-occurring terminal illness,
  • patient was diagnosed with forms of dementia with clinical profiles that would preclude participation (e.g., Frontotemporal Dementia- behavioral variant), as determined by treatment team.

Other

  • patient is deemed inappropriate by the neurology team,

Criteria the registry did not label

  • PWD inclusion criteria are:
  • Recent (\~1 month) chart documented ADRD diagnosis,
  • ADRD symptom onset after age 65 ,
  • cognitive assessment scores and symptoms consistent with early stage dementia, as determined by the Clinical Dementia Rating Scale scores of .5 or 1.0
  • cognitive awareness of his/her problems (as determined by the treating neurologist), and
  • ability to understand study and research protocol, as determined by a standardized teach-back method assessment84.
    • Additional inclusion criteria for dyads are:
  • English speaking adults (18 years or older),
  • dyad lives together,
  • at least one partner endorses clinically significant emotional distress during screening (\>7 on Hospital Anxiety and Depression scale subscales)

Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Brain Injury Research Center at Mount Sinai
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.